Potentially fatal cerebral venous sinus thrombosis followed by a hemorrhagic stroke in a vaccinated patient: do not rule out COVID-19 as a reason

Автор: Mishra M.K., Sahu A.

Журнал: Juvenis scientia @jscientia

Рубрика: Клинические случаи

Статья в выпуске: 5 т.9, 2023 года.

Бесплатный доступ

Stroke is amongst the leading causes of morbidity and mortality globally. Majority of strokes are ischemic and up to 1/3rd ischemic strokes have infective etiology. In this post-pandemic era, SARS-CoV-2 is an established infectious agent which can precipitate it by various mechanisms. Though post-vaccination incidence of COVID-19 has dropped drastically, still new cases get reported with typical or atypical presentations. Irrespective of causation, malignant cerebral edema in stroke necessitates salvage neurosurgery. Hereby authors present an interesting diagnostic chase in a young female who presented in altered sensorium, underwent emergency decompressive craniectomy and neurologically recovered over subsequent days. Despite being double vaccinated, she developed potentially fatal COVID-encephalitis, cerebral venous sinus thrombosis (CVST), ischemic infarcts and hemorrhagic transformation. Suprisingly, there were cross reacting antibodies against antigens of herpes simplex virus (HSV), leptospira and cytomegalovirus (CMV) yielding false positivity on serology screening test, which spoofed us while carrying out infectious disease work up of stroke.


Covid-19, sars-cov-2, decompressive craniectomy, cerebral venous sinus thrombosis, cross reacting antibody, stroke, hemorrhagic infarct

Короткий адрес: https://sciup.org/14128750

IDR: 14128750   |   DOI: 10.32415/jscientia_2023_9_5_45-52

Список литературы Potentially fatal cerebral venous sinus thrombosis followed by a hemorrhagic stroke in a vaccinated patient: do not rule out COVID-19 as a reason

  • Saini V, Guada L, Yavagal DR. Global Epidemiology of Stroke and Access to Acute Ischemic Stroke Interventions. Neurology. 2021;97(20 Suppl 2):S6-S16. DOI: 10.1212/WNL.0000000000012781.
  • Saberi A, Akhondzadeh S, Kazemi S, Kazemi S. Infectious Agents and Stroke: A Systematic Review. Basic Clin Neurosci. 2021;12(4):427-440. DOI: 10.32598/bcn.2021.1324.2.
  • Dakay K, Cooper J, Bloomfield J, et al. Cerebral Venous Sinus Thrombosis in COVID-19 Infection: A Case Series and Review of The Literature. J Stroke Cerebrovasc Dis. 2021;30(1):105434. DOI: 10.1016/j.jstrokecerebrovasdis.2020.105434.
  • Miraclin T A, Aaron DS, Sivadasan A, et al. Management and Outcomes of COVID-19 Associated Cerebral Venous Sinus Thrombosis. J Stroke Cerebrovasc Dis. 2022;31(4):106306. DOI: 10.1016/j.jstrokecerebrovasdis.2022.106306.
  • Nannoni S, de Groot R, Bell S, Markus HS. Stroke in COVID-19: A systematic review and meta-analysis. Int J Stroke. 2021;16(2):137-149. DOI: 10.1177/1747493020972922.
  • Ehret J, Al Safi A, Akabusi C, et al. A Case Report of Herpes Simplex-1 Viral Encephalitis Complicated by Hemorrhagic Conversion. Cureus. 2022;14(4):e24255. DOI: 10.7759/cureus.24255.
  • Vandervore L, Van Mieghem E, Nowé V, et al. False positive Herpes Simplex IgM serology in COVID-19 patients correlates with SARS-CoV-2 IgM/IgG seropositivity. Diagn Microbiol Infect Dis. 2022;103(1):115653. DOI: 10.1016/j.diagmicrobio.2022.115653.
  • Luvira V, Leaungwutiwong P, Thippornchai N, et al. False Positivity of Anti-SARS-CoV-2 Antibodies in Patients with Acute Tropical Diseases in Thailand. Trop Med Infect Dis. 2022;7(7):132. DOI: 10.3390/tropicalmed7070132.
  • Pramod S, Govindan D, Ramasubramani P, et al. Effectiveness of Covishield vaccine in preventing Covid-19 — A test-negative case-control study. Vaccine. 2022;40(24):3294-3297. DOI: 10.1016/j.vaccine.2022.02.014.
  • Ayoubkhani D, Bosworth ML, King S, et al. Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study. Open Forum Infect Dis. 2022;9(9):ofac464. DOI: 10.1093/ofid/ofac464.
  • Favresse J, Bayart JL, Mullier F, et al. Antibody titres decline 3-month post-vaccination with BNT162b2. Emerg Microbes Infect. 2021;10(1):1495-1498. DOI: 10.1080/22221751.2021.1953403.
  • Kusunoki H, Ekawa K, Ekawa M, et al. Trends in Antibody Titers after SARS-CoV-2 Vaccination-Insights from Self-Paid Tests at a General Internal Medicine Clinic. Medicines (Basel). 2023;10(4):27. DOI: 10.3390/medicines10040027.
  • Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767-783. DOI: 10.1016/S1474-4422(20)30221-0.
Статья научная